Integra LifeSciences Announces Key Executive Appointments
(Thomson Reuters ONE) -
PLAINSBORO, N.J., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences
Holdings Corporation (Nasdaq:IART) today announced key executive appointments
effective December 1, 2016.
* Robert T. Davis, Jr., corporate vice president and president, Specialty
Surgical Solutions (SSS), has been named corporate vice president and
president, Orthopedics and Tissue Technologies.
* Dan Reuvers, corporate vice president and president, International, will
assume the role of corporate vice president and president, SSS.
* Glenn Coleman, corporate vice president, chief financial officer and
principal accounting officer, in addition to his current responsibilities,
will assume oversight of the international business. A leader for the
international business will be later named reporting into Mr. Coleman.
All three executives will continue to be members of the Integra executive
leadership team, reporting to Peter Arduini, Integra president and chief
executive officer.
"These key leadership appointments reflect the depth and strength of our
management team, enabling us to promote executives from within the company,"
said Peter Arduini. "Bob, Dan and Glenn are proven leaders who have demonstrated
exemplary management capabilities over the years and a track record of
accomplishments that have contributed to our strong business performance."
Robert T. Davis, Jr. brings more than 25 years of executive management
experience in the global healthcare industry. He joined Integra in 2012 as
president of the global neurosurgery business and was appointed corporate vice
president in December 2012 and president of the SSS division in 2014.
Dan Reuvers has more than 25 years of experience in the medical technology
field, including holding various executive level positions in sales, marketing
and general management. Mr. Reuvers joined Integra in 2008 as vice president of
marketing and product development for Integra's surgical business. He was
promoted to president of the acute surgical business in 2010 and appointed
president of the instruments business in 2011. Mr. Reuvers was named corporate
vice president in 2012 and became president of the international business in
2013.
Glenn Coleman joined Integra as corporate vice president, chief financial
officer and principal accounting officer in 2014, bringing 25 years of
experience in financial management with leading global corporations. Mr. Coleman
has been a certified public accountant in New Jersey for more than 20 years.
About Integra
Integra LifeSciences Holdings Corporation, a world leader in medical technology,
is dedicated to limiting uncertainty for clinicians, so they can concentrate on
providing the best patient care. Integra offers innovative solutions, including
leading plastic and regenerative technologies, in specialty surgical solutions,
orthopedics and tissue technologies. For more information, please
visit www.integralife.com.
This news release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include, but are not limited to, statements concerning the products and services
provided by Integra. Such forward-looking statements involve risks and
uncertainties that could cause actual results to differ materially from
predicted or expected results. Among other things, the willingness of surgical
professionals to use Integra products may affect the prospects for their use in
surgical procedures. In addition, the economic, competitive, governmental,
technological and other factors, identified under the heading "Risk Factors"
included in Item IA of Integra's Annual Report on Form 10-K for the year ended
December 31, 2015 and information contained in subsequent filings with the
Securities and Exchange Commission could affect actual results.
CONTACT: Integra LifeSciences Holdings Corporation
Investors
Angela Steinway
609-936-2268
angela.steinway(at)integralife.com
Michael Beaulieu
609-750-2827
michael.beaulieu(at)integralife.com
Media
Laurene Isip
609-750-7984
laurene.isip(at)integralife.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Integra LifeSciences Holdings Corp. via GlobeNewswire
Bereitgestellt von Benutzer: hugin
" alt="Brazil Resources Announces Name Change to "GoldMining Inc." and New Symbols "GOLD" in Canada and "GLDLF" in the U.S.Datum: 05.12.2016 - 14:30 Uhr
Sprache: Deutsch
News-ID 510867
Anzahl Zeichen: 5035
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 294 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Integra LifeSciences Announces Key Executive Appointments"
steht unter der journalistisch-redaktionellen Verantwortung von
Integra LifeSciences Holdings Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
